Our patient, Merab Merkiladze, defeated prostate cancer in just one day without surgery, thanks to a revolutionary robotic method – the FOCAL ONE RUTH therapy.
Professor Guram Karazanashvili speaks on “Imedis Dila” morning show about the ultra-modern medical breakthrough that is radically changing traditional prostate cancer treatment methods. Even in the world’s leading countries, this technology is only now being introduced, and within the country, the region, and the surrounding area, it is available exclusively at the Karazanashvili Robotic Center Prostate Diagnosis and Treatment Center.
Prostate Cancer Treatment Using Robotic Method
Focal One (RUTH – Robotic Ultrasound Therapy) is intended for patients diagnosed with localized prostate cancer. Thanks to this unique, organ-sparing robotic technology, affected men have the opportunity to defeat prostate cancer while preserving the prostate, maintaining normal sexual function and urinary continence, and leaving the hospital healthy just a few hours later.
Focal One (RUTH) works by integrating high-resolution magnetic resonance imaging (MRI), ultrasound, and biopsy data. This technology allows doctors to view the prostate at the cellular level in three dimensions and plan treatment individually, based on the 3D image. Guided by a navigation system developed by the urologist, robotic ultrasound therapy (RUTH) is performed on the prostate cancer: the robot automatically directs the probe toward the tumor, executes the instructions with precision, adjusts in real time as necessary, and destroys only the affected area of the prostate, leaving surrounding tissue and organs unharmed. As a result, the patient is freed from prostate cancer while preserving the prostate, normal sexual function, and urinary control.
It is noteworthy that during robotic ultrasound therapy for prostate cancer, there is no need for any surgical incisions, eliminating all surgical risks. It does not require puncture, no foreign materials are left in the body, no ionizing or radioactive radiation is used, no hospitalization or multiple treatment sessions are needed. The patient is discharged from the clinic within a few hours and, most importantly, after being freed from cancer, can maintain a full and high-quality life.
Focal One “RUTH” is recognized as an ultra-modern, non-surgical, non-invasive, radiation-free robotic therapy for prostate cancer and has been approved by the United States Food and Drug Administration (FDA). This highly authoritative American organization is, in fact, the global leader responsible for ensuring and approving the safety and effectiveness of medicines, medical devices, food products, and vaccines in public healthcare.
